Rui Ling - Publications, H-index & Citations

Rui Ling

Fourth Military Medical University

22H指数

131论文数

1.7K被引数

收录论文 32

发表时间

Efficacy comparison of toripalimab versus pembrolizumab in neoadjuvant treatment of breast cancer: impact of chemotherapy regimen and sequence on pathologic complete response 曲安西 romab 与帕博利珠单抗在乳腺癌新辅助治疗中的疗效比较：化疗方案及顺序对病理完全缓解的影响

Frontiers in Oncology

IF3.3

2025-12-19

OAAI

Yunjiao Zhang†; Bo Zhang†; Xi Chen†; Xue Zhang; Chutuo Liu; Zhe Wang; Rui Ling

Personalized risk prediction of lateral lymph node metastasis in male papillary thyroid cancer: a sex-specific model leveraging central lymph node ratio 男性乳头状甲状腺癌的侧方淋巴结转移个性化风险预测：一种利用中央淋巴结比例的性别特异性模型

Future Oncology

IF2.6

2025-10-31

OAAI

Xue Zhang; Yuan Qin; Niuniu Hou; Yunjiao Zhang; Changjiao Yan; Xi Chen; Chutuo Liu; Chong Chen; Rui Ling

Dual-Frequency Power Amplifiers’ Design Based on Improved Multiobjective Particle Swarm Optimization Algorithm Ling, R.; Zhang, Z.; Xuan, X. 基于改进多目标粒子群优化算法的双频功率放大器设计. IEEE Microw. Wirel. Technol. Lett. 2025, 1–4. [Google Scholar] [CrossRef]

IEEE Microwave and Wireless Technology Letters

IF3.4

2025-07-31

PREAI

Rui Ling; Zhiwei Zhang; Xuefei Xuan

KLF13 promotes breast cancer progression through the HTRA1 and the Hedgehog signaling pathway KLF13通过HTRA1和Hedgehog信号通路促进乳腺癌进展

Breast Cancer

IF2.9

2025-06-24

PREAI

Meiling Huang; Jian Zhang; Changjiao Yan; Rui Ling; Ting Wang

Radiotherapy and increased risk of second primary cancers in breast cancer survivors: An epidemiological and large cohort study 放疗与乳腺癌幸存者第二原发癌风险增加: 一项流行病学和大型队列研究

BREAST

IF7.9

2024-12-01

OAAI

Hou, Niuniu; Wang, Zhe; Ling, Yuwei; Hou, Guangdong; Zhang, Bo; Zhang, Xue; Shi, Mei; Chu, Zhuling; Wang, Yaoling; Hu, Jun; Chen, Chong; Ling, Rui

Personalized human-computer interaction as an information source for ride-hailing platforms: behavior intention perspective

ASIA PACIFIC JOURNAL OF MARKETING AND LOGISTICS

IF5.1

2024-08-13

PREAI

Li, Jing; Ling, Rui; Sun, Fangjie; Zhou, Jinming; Cai, Haiya

XBP1s activates METTL3/METTL14 for ER-phagy and paclitaxel sensitivity regulation in breast cancer

CANCER LETTERS

IF10.1

2024-08-01

PREAI

Wang, Jiajia; Fan, Pengyu; Shen, Peng; Fan, Cong; Zhao, Pan; Shen, Yao; Dong, Kewei; Ling, Rui; Chen, Suning; Zhang, Jian

Oncostatin M-driven macrophage-fibroblast circuits as a drug target in autoimmune arthritis 抑瘤素M驱动的巨噬细胞-成纤维细胞回路作为自身免疫性关节炎的药物靶标

INFLAMMATION AND REGENERATION

IF6.6

2024-07-31

OAAI

Huynh, Nam Cong-Nhat; Ling, Rui; Komagamine, Masatsugu; Shi, Tianshu; Tsukasaki, Masayuki; Matsuda, Kotaro; Okamoto, Kazuo; Asano, Tatsuo; Muro, Ryunosuke; Pluemsakunthai, Warunee; Kollias, George; Kaneko, Yuko; Takeuchi, Tsutomu; Tanaka, Sakae; Komatsu, Noriko; Takayanagi, Hiroshi

Clinical practice guidelines for neoadjuvant therapy in patients with early-stage breast cancer: Chinese Society of Breast Surgery practice guidelines 2022

CHINESE MEDICAL JOURNAL

IF7.3

2024-05-23

OAAI

Zhang, Juliang; Wang, Ting; Wang, Zhe; Fan, Jing; Xu, Xiaolong; Kong, Jing; Wen, Xinxin; Ling, Rui; Liu, Yinhua

Identifying potential breath biomarkers for early diagnosis of papillary thyroid cancer based on solid-phase microextraction gas chromatography-high resolution mass spectrometry with metabolomics

METABOLOMICS

IF3.3

2024-05-21

PREAI

Li, Lan; Wen, Xinxin; Li, Xian; Yan, Yaqi; Wang, Jiayu; Zhao, Xuyang; Tian, Yonghui; Ling, Rui; Duan, Yixiang

Comprehensive characterization and detection of nut allergens in bakery foods using Q-TOF mass spectrometry and bioinformatics

FOOD QUALITY AND SAFETY

IF4.4

2023-11-29

OAAI

Xu, Daokun; Huang, Haolun; Liu, Zhen; Wang, Yumei; Liu, Qinan; Jiang, Xing; Yang, Jun; Ling, Rui

Association of a complete breast cancer pathologic response with axillary lymph node metastasis via neoadjuvant chemotherapy: Results from the CSBrS-012 study

CHINESE MEDICAL JOURNAL

IF7.3

2023-10-25

OAAI

Ma, Le; Gao, Pin; Liu, Zhenzhen; Jiao, Dechuang; Ling, Rui; Xiao, Jingjing; Zhao, Yi; Wang, Yitong; Yang, Hongjian; Liu, Yunjiang; Liu, Ke; Zhang, Jianguo; Li, Guangyan; Mao, Dahua; Deng, Yinglei; He, Jianjun; Amina, Maimaitiaili; Yu, Zhigang; Fei, Wang; Liu, Yinhua; Fu, Peifen; Yao, Minya; Wang, Jiandong; Zhu, Li; Jiang, Hongchuan; Zhao, Zuowei; Tian, Xingsong; Cao, Zhongwei; Ma, Xinyu; Wu, Kejin; Fu, Shaomei; Song, Ailin; Wang, Yanwei; Feng, Jin; Fan, Zhimin

Effect of JAK inhibitors on the three forms of bone damage in autoimmune arthritis: joint erosion, periarticular osteopenia, and systemic bone loss

INFLAMMATION AND REGENERATION

IF6.6

2023-09-19

OAAI

Komagamine, Masatsugu; Komatsu, Noriko; Ling, Rui; Okamoto, Kazuo; Tianshu, Shi; Matsuda, Kotaro; Takeuchi, Tsutomu; Kaneko, Yuko; Takayanagi, Hiroshi

Development and validation of an endoplasmic reticulum stress-related molecular prognostic model for breast cancer

FRONTIERS IN ONCOLOGY

IF3.3

2023-05-29

OAAI

Fan, Pengyu; Wang, Jiajia; Li, Ruolei; Chang, Kexin; Liu, Liuyin; Wang, Yaping; Wang, Zhe; Zhang, Bo; Ji, Cheng; Zhang, Jian; Chen, Suning; Ling, Rui

Efficacy analysis of neoadjuvant chemotherapy with or without anthracyclines in female patients with HER2-positive breast cancer in China: a nationwide, multicenter, 10-year retrospective study (CSBrS-012)

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY

IF4.2

2023-02-28

OAAI

Chen, Heyan; Maimaitiaili, Amina; Liu, Zhenzhen; Ling, Rui; Zhao, Yi; Yang, Hongjian; Liu, Yunjiang; Liu, Ke; Zhang, Jianguo; Mao, Dahua; Yu, Zhigang; Liu, Yinhua; Fu, Peifen; Wang, Jiandong; Jiang, Hongchuan; Zhao, Zuowei; Tian, Xingsong; Cao, Zhongwei; Wu, Kejin; Song, Ailin; Jin, Feng; He, Jianjun; Fan, Zhimin; Zhang, Huimin

Development of a headspace-solid phase microextraction gas chromatography-high resolution mass spectrometry method for analyzing volatile organic compounds in urine: Application in breast cancer biomarker discovery

CLINICA CHIMICA ACTA

IF2.9

2023-02-01

PREAI

Li, Xian; Wen, Xinxin; Luo, Zewei; Tian, Yonghui; Qian, Cheng; Zhang, Jing; Ling, Rui; Duan, Yixiang

Construction of a ferroptosis-related five-lncRNA signature for predicting prognosis and immune response in thyroid carcinoma

CANCER CELL INTERNATIONAL

IF6

2022-09-29

OAAI

Qin, Yuan; Zhang, Dai; Zhang, Huan; Hou, Lan; Wang, Zhe; Yang, Liu; Zhang, Mingkun; Zhao, Ge; Yao, Qing; Ling, Rui; Zhang, Juliang

PRMT5 regulates RNA m6A demethylation for doxorubicin sensitivity in breast cancer

MOLECULAR THERAPY

IF12

2022-07-01

OAAI

Wu, Ying; Wang, Zhe; Han, Lu; Guo, Zhihao; Yan, Bohua; Guo, Lili; Zhao, Huadong; Wei, Mengying; Hou, Niuniu; Ye, Jing; Wang, Zhe; Shi, Changhong; Liu, Suling; Chen, Ceshi; Chen, Suning; Wang, Ting; Yi, Jun; Zhou, JianPing; Yao, Libo; Zhou, Wenxia; Ling, Rui; Zhang, Jian

Diagnostic approach to thyroid cancer based on amino acid metabolomics in saliva by ultra-performance liquid chromatography with high resolution mass spectrometry 基于唾液氨基酸代谢组学的甲状腺癌超高效液相色谱-高分辨质谱诊断方法

TALANTA

IF6.1

2021-12-01

PREAI

Zhang, Jing; Wen, Xinxin; Li, Yuting; Zhang, Jing; Li, Xian; Qian, Cheng; Tian, Yonghui; Ling, Rui; Duan, Yixiang

Development, verification, and comparison of a risk stratification model integrating residual cancer burden to predict individual prognosis in early-stage breast cancer treated with neoadjuvant therapy

ESMO OPEN

IF8.3

2021-10-01

OAAI

Hou, N.; Wu, J.; Xiao, J.; Wang, Z.; Song, Z.; Ke, Z.; Wang, R.; Wei, M.; Xu, M.; Wei, J.; Qian, X.; Xu, X.; Yi, J.; Wang, T.; Zhang, J.; Li, N.; Fan, J.; Hou, G.; Wang, Y.; Wang, Z.; Ling, R.

研究方向